Purchases and Sales Made in Q3 2023 in Mersana Therapeutics, Inc. (MRSN)
This table provides information about the institutional ownership of Mersana Therapeutics, Inc. (MRSN) during Q3 2023. The information is specifically focused on institutions that hold shares of Mersana Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Sarissa Capital Management LP
Greenwich, CT |
SELL
|
- |
-2.08M- 79.11% |
$2.21M - $8.14M
|
550K
$1.22M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-2.55M- 94.18% |
$2.71M - $9.98M
|
158K
$350K
|
|
|
Nov 14, 2023
Q3 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.59M- 52.85% |
$2.75M - $10.1M
|
2.31M
$5.13M
|